Elos Medtech – Annual Report 2018 published

The Swedish version of Elos Medtech Annual Report 2018 have today been published on our web site www.elosmedtech.com

The English version of Elos Medtech Annual Report 2018 will be available at the web site www.elosmedtech.com in late April.

Göteborg, April 2, 2019

Elos Medtech AB (publ)

For further information, please contact: Jan Wahlström, CEO, +46 70 212 18 89, jan.wahlstrom@elosmedtech.com  or Christian Bergaust CFO, +46 70 293 50 40, christian.bergaust@elosmedtech.com

For additional information about the Elos Medtech Group, visit www.elosmedtech.com

This information is information that Elos Medtech AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above on April 2, 2019, at 08:30 (CET).

Tags:

About Us

Elos Medtech is one of the leading development and production partners for medical technology products and components, such as dental and orthopaedic implants and instruments. The operations are conducted at facilities in Sweden, Denmark, China and USA. Customers are mainly internationally active medical technology companies in the market segments Dental , Orthopedics and Life Science. Elos Medtech employs more than 550 people worldwide and generates revenue that exceeds MSEK 600. Elos Medtech has been traded on NASDAQ Stockholm AB since 1989. The Elos Medtech B share is classified as a Health Care company on the Small Cap list.

Subscribe